{"id":18232,"date":"2026-04-01T13:31:26","date_gmt":"2026-04-01T13:31:26","guid":{"rendered":"https:\/\/www.colorectalcancercanada.com\/?post_type=drug&#038;p=18232"},"modified":"2026-04-08T16:38:58","modified_gmt":"2026-04-08T16:38:58","slug":"5-fluorouracil-5-fu","status":"publish","type":"drug","link":"https:\/\/www.colorectalcancercanada.com\/fr\/drug\/5-fluorouracil-5-fu\/","title":{"rendered":"5-Fluorouracil (5-FU)"},"content":{"rendered":"<p><strong>Indication :<\/strong><\/p>\n<p>Utilis\u00e9 dans le traitement du cancer colorectal, principalement en association avec d&rsquo;autres agents chimioth\u00e9rapeutiques, tant en traitement adjuvant que dans les cas de m\u00e9tastases. Il est couramment utilis\u00e9 avec la leucovorine pour renforcer l&rsquo;activit\u00e9 antitumorale et constitue la base de sch\u00e9mas th\u00e9rapeutiques standard tels que le FOLFOX (5-FU\/leucovorine\/oxaliplatine), le FOLFIRI (5-FU\/leucovorine\/irinot\u00e9can) et le FOLFOXIRI.<\/p>\n","protected":false},"template":"","crc_subtype":[401],"drug_stage":[416,417,402],"therapy_line":[418],"health_canada_approval":[404],"cda_review":[],"cda_recommendation":[],"inesss_review":[],"inesss_recommendation":[],"pcpa_status":[],"public_reimbursement":[411,410,454,450,451,414,457,453,413,412,452,456,455],"class_list":["post-18232","drug","type-drug","status-publish","hentry","crc_subtype-none-fr","drug_stage-ii-fr","drug_stage-iii-fr","drug_stage-iv-fr","therapy_line-premiere-ligne","health_canada_approval-approved-fr","public_reimbursement-alberta-fr","public_reimbursement-colombie-britannique-fr","public_reimbursement-i-p-e","public_reimbursement-manitoba-fr","public_reimbursement-n-b","public_reimbursement-ns-fr","public_reimbursement-nt","public_reimbursement-on","public_reimbursement-qc-fr","public_reimbursement-sk-fr","public_reimbursement-t-n-l","public_reimbursement-t-n-o","public_reimbursement-yn"],"_links":{"self":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/drug\/18232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/drug"}],"about":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/types\/drug"}],"wp:attachment":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/media?parent=18232"}],"wp:term":[{"taxonomy":"crc_subtype","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/crc_subtype?post=18232"},{"taxonomy":"drug_stage","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/drug_stage?post=18232"},{"taxonomy":"therapy_line","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/therapy_line?post=18232"},{"taxonomy":"health_canada_approval","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/health_canada_approval?post=18232"},{"taxonomy":"cda_review","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/cda_review?post=18232"},{"taxonomy":"cda_recommendation","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/cda_recommendation?post=18232"},{"taxonomy":"inesss_review","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/inesss_review?post=18232"},{"taxonomy":"inesss_recommendation","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/inesss_recommendation?post=18232"},{"taxonomy":"pcpa_status","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/pcpa_status?post=18232"},{"taxonomy":"public_reimbursement","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/public_reimbursement?post=18232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}